main navigation
MSGPP - Home
Project Description
  Flow Diagrams
Contact Information
  Program Project Members
Target Diseases & Organisms
* Malaria
   Plasmodium falciparum
   Plasmodium vivax
* Chagas' Disease
    [American Trypanosomiasis]
   Trypanosoma cruzi
* Sleeping Sickness
    [African Trypanosomiasis]
   Trypanosoma brucei
* Leishmaniasis
   Leishmania spp.
* Amoebiasis
   Entamoeba histolytica
* Giardiasis
   Giardia lamblia
* Toxoplasmosis
   Toxoplasma gondii
* Cryptosporidiosis
   Cryptosporidium parvum
Genome Databases
Target Progress
Ligand Screening
Papers by MSGPP
Related Links/Resources
Employment Opportunities
MSGPP

CRYPTOSPORIDIOSIS
Cryptosporidum parvum

Cryptosporidiosis (Cryptosporidium parvum): This diarrheal disease was made famous by an outbreak in Milwaukee afflicting 403,000 persons in 1993. The outbreak was associated with water contamination traced to cow feces. Healthy individuals often experience 1-2 weeks of watery diarrhea, whereas immune compromised individuals can have chronic symptoms that can be very difficult to eradicate. Only one treatment, nitizoxanide, has an established role in treating cryptosporidiosis. Because of the potential for malicious introduction into public water supplies, C. parvum is considered a Biodefense agent.


Organism Cryptosporidium parvum
At Risk Immunocompromised worldwide
Humans Infected Seroprevalance ~30% in USA
Disease Outcome Prolonged, life threatening
Vaccine Prospects  
Available Drugs Generally unresponsive
Drug Resistance

 

Life cycle of Cryptosporidium parvum. Cryptosporidium stages were reproduced from Juranek, DD. Cryptosporidiosis. In: Strickland GT, editor. Hunter’s Tropical Medicine and Emerging Infectious Diseases, 8th ed. Philadelphia: WB Saunders; 2000.  Originally adapted from the life cycle that appears in Current WL, Garcia LS. Cryptosporidiosis. Clinc Microbiol Rev 1991;4:325-58

 

General Information: Medline, Centers for Disease Control